HK1249441A1 - Pharmaceutical composition with improved storage stability and method for preparing the same - Google Patents
Pharmaceutical composition with improved storage stability and method for preparing the sameInfo
- Publication number
- HK1249441A1 HK1249441A1 HK18109126.8A HK18109126A HK1249441A1 HK 1249441 A1 HK1249441 A1 HK 1249441A1 HK 18109126 A HK18109126 A HK 18109126A HK 1249441 A1 HK1249441 A1 HK 1249441A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- preparing
- pharmaceutical composition
- same
- storage stability
- improved storage
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20150106629 | 2015-07-28 | ||
PCT/KR2016/008270 WO2017018820A1 (en) | 2015-07-28 | 2016-07-28 | Pharmaceutical composition with improved storage stability and method for preparing the same |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1249441A1 true HK1249441A1 (en) | 2018-11-02 |
Family
ID=57884713
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18109126.8A HK1249441A1 (en) | 2015-07-28 | 2018-07-13 | Pharmaceutical composition with improved storage stability and method for preparing the same |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP3328437A4 (en) |
JP (1) | JP2018521105A (en) |
KR (1) | KR101787453B1 (en) |
CN (1) | CN107466231A (en) |
AU (1) | AU2016299548A1 (en) |
BR (1) | BR112018001737A2 (en) |
CA (1) | CA2993928A1 (en) |
HK (1) | HK1249441A1 (en) |
IL (1) | IL257187A (en) |
MX (1) | MX2018001223A (en) |
RU (1) | RU2018107055A (en) |
WO (1) | WO2017018820A1 (en) |
ZA (1) | ZA201801187B (en) |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6020507A (en) | 1998-03-02 | 2000-02-01 | Bristol-Myers Squibb Company | Synthesis of paclitaxel from baccatin III by protection of the 7-hydroxyl of baccatin III using a strong base and an electrophile |
NZ522442A (en) * | 2000-05-12 | 2004-04-30 | Samyang Corp | Method for the preparation of polymeric micelle via phase separation of block copolymer |
US7217770B2 (en) * | 2000-05-17 | 2007-05-15 | Samyang Corporation | Stable polymeric micelle-type drug composition and method for the preparation thereof |
MXPA04003621A (en) * | 2001-10-18 | 2004-07-30 | Samyang Corp | Polymeric micelle composition with improved stability. |
WO2005037840A1 (en) | 2003-10-16 | 2005-04-28 | Mayne Pharma (Usa), Inc. | Method for inverting the c2’ hydroxyl group of taxane esters |
KR101024742B1 (en) * | 2007-12-31 | 2011-03-24 | 주식회사 삼양사 | Amphiphilic Block Copolymer Micelle Composition Containing Taxane and Manufacturing Process of The Same |
US9801818B2 (en) * | 2007-12-31 | 2017-10-31 | Samyang Biopharmaceuticals Corporation | Method for stabilizing amphiphilic block copolymer micelle composition containing poorly water-soluble drug |
WO2009091150A2 (en) * | 2007-12-31 | 2009-07-23 | Samyang Corporation | Highly pure amphiphilic copolymer comprising hydrophobic block from alpha-hydroxy acid and process for the preparation thereof |
EP2201935B1 (en) * | 2008-12-26 | 2020-07-08 | Samyang Biopharmaceuticals Corporation | Polymeric micelle composition containing a poorly soluble drug and preparation method of the same |
-
2016
- 2016-07-27 KR KR1020160095415A patent/KR101787453B1/en active IP Right Grant
- 2016-07-28 WO PCT/KR2016/008270 patent/WO2017018820A1/en active Application Filing
- 2016-07-28 EP EP16830853.4A patent/EP3328437A4/en not_active Withdrawn
- 2016-07-28 AU AU2016299548A patent/AU2016299548A1/en not_active Abandoned
- 2016-07-28 CA CA2993928A patent/CA2993928A1/en not_active Abandoned
- 2016-07-28 CN CN201680001947.1A patent/CN107466231A/en active Pending
- 2016-07-28 RU RU2018107055A patent/RU2018107055A/en unknown
- 2016-07-28 BR BR112018001737A patent/BR112018001737A2/en not_active Application Discontinuation
- 2016-07-28 MX MX2018001223A patent/MX2018001223A/en unknown
- 2016-07-28 JP JP2018504263A patent/JP2018521105A/en active Pending
-
2018
- 2018-01-28 IL IL257187A patent/IL257187A/en unknown
- 2018-02-21 ZA ZA2018/01187A patent/ZA201801187B/en unknown
- 2018-07-13 HK HK18109126.8A patent/HK1249441A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR101787453B1 (en) | 2017-10-19 |
BR112018001737A2 (en) | 2018-09-11 |
ZA201801187B (en) | 2018-12-19 |
KR20170015200A (en) | 2017-02-08 |
WO2017018820A1 (en) | 2017-02-02 |
JP2018521105A (en) | 2018-08-02 |
CN107466231A (en) | 2017-12-12 |
MX2018001223A (en) | 2018-11-09 |
CA2993928A1 (en) | 2017-02-02 |
IL257187A (en) | 2018-03-29 |
RU2018107055A (en) | 2019-08-28 |
EP3328437A4 (en) | 2019-03-20 |
EP3328437A1 (en) | 2018-06-06 |
RU2018107055A3 (en) | 2019-08-28 |
AU2016299548A1 (en) | 2018-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL289099A (en) | Methods for the storage of whole blood, and compositions thereof | |
EP3130355A4 (en) | Pharmaceutical composition containing pregabalin with improved stability and method for preparing same | |
IL251703A0 (en) | Pharmaceutical composition with improved stability | |
ZA201703398B (en) | Pharmaceutical composition and methods | |
HRP20200104T8 (en) | Novel heterocyclic compound, method for preparing the same, and pharmaceutical composition comprising the same | |
HK1214767A1 (en) | Tablet-formed pharmaceutical composition and preparation method thereof | |
IL257621B (en) | Novel catechol derivatives and pharmaceutical composition comprising the same | |
HK1249439A1 (en) | Pharmaceutical composition with improved storage stability and method for preparing the same | |
HK1249442A1 (en) | Pharmaceutical composition with improved storage stability and method for preparing the same | |
EP3384933C0 (en) | Anhydrosugar alcohol composition having enhanced storage stability, and anhydrosugar alcohol storage method | |
EP3305283A4 (en) | Stabilized pharmaceutical composition and method for preparing same | |
SI3250188T1 (en) | Pharmaceutical composition comprising aprepitant and method for the preparation thereof | |
HK1249440A1 (en) | Pharmaceutical composition with improved storage stability and method for preparing the same | |
HK1249441A1 (en) | Pharmaceutical composition with improved storage stability and method for preparing the same | |
PL3324971T3 (en) | Zolpidem composition and process for preparing the same | |
EP3344661C0 (en) | Iron-polysaccharide complexes and methods for the preparation thereof | |
IL230801A0 (en) | Stable sulfur-containing solid composition and method for manufacturing the same |